Top

Published in:

17-05-2022 | Fatty Liver | Editorial

MAFLD Versus NAFLD: Which Better Predicts the Risk of Atherosclerotic Cardiovascular Disease?

Authors: Andrew R. Scheinberg, Binu V. John

Published in: Digestive Diseases and Sciences | Issue 10/2022

Excerpt

Non-alcoholic fatty liver disease (NAFLD) is a progressive chronic liver disease that if untreated may progress to cirrhosis and the development of its complications including hepatocellular carcinoma (HCC) [1]. With the successful and widely-available treatment of hepatitis C virus (HCV) infection globally combined with an unfortunate booming obesity epidemic, NAFLD has emerged as the leading cause of end-stage liver disease. …

Li B, Zhang C, Zhan YT. nonalcoholic fatty liver disease cirrhosis: a review of its epidemiology, risk factors, clinical presentation, diagnosis, management, and prognosis. Can J Gastroenterol Hepatol 2018;2018:2784537.CrossRef

Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, Harrison SA, Brunt EM, Sanyal AJ. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American association for the study of liver diseases. Hepatology 2018;67(1):328–357.CrossRef

Eslam M, Sanyal AJ, George J. MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology 2020;158:1999–2014.e1.CrossRef

Kim H. MAFLD predicts the risk of cardiovascular disease better than NAFLD in asymptomatic subjects with health check-ups. Dig Dis Sci. (Epub ahead of print). https://doi.org/10.1007/s10620-022-07508-6.

Nguyen VH, Le MH, Cheung RC, Nguyen MH. Differential clinical characteristics and mortality outcomes in persons with NAFLD and/or MAFLD. Clin Gastroenterol Hepatol 2021;19:2172–2181.CrossRef

Kim D, Konyn P, Sandhu KK, Dennis BB, Cheung AC, Ahmed A. Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States. J Hepatol 2021;75:1284–1291.CrossRef

Kim D, Ahmed A. Reply to: “NAFLD vs MAFLD - It is not the name but the disease that decides the outcome in fatty liver.” J Hepatol. 2022;76:477–478.CrossRef

Lim GEH, Tang A, Ng CH, Chin YH, Lim WH, Tan DJH, Yong JN, Xiao J, Lee CW, Chan M, Chew NW, Xuan Tan EX, Siddiqui MS, Huang D, Noureddin M, Sanyal AJ, Muthiah MD. An observational data meta-analysis on the differences in prevalence and risk factors between MAFLD vs NAFLD. Clin Gastroenterol Hepatol. 2021. https://doi.org/10.1016/j.cgh.2021.11.038.CrossRefPubMed

Yamamura S, Eslam M, Kawaguchi T, Tsutsumi T, Nakano D, Yoshinaga S, Takahashi H, Anzai K, George J, Torimura T. MAFLD identifies patients with significant hepatic fibrosis better than NAFLD. Liver Int. 2020;40:3018–3030.CrossRef

10.

Sun DQ, Jin Y, Wang TY, Zheng KI, Rios RS, Zhang HY, Targher G, Byrne CD, Yuan WJ, Zheng MH. MAFLD and risk of CKD. Metabolism. 2021;115:154433.CrossRef

Title: MAFLD Versus NAFLD: Which Better Predicts the Risk of Atherosclerotic Cardiovascular Disease?
Authors: Andrew R. Scheinberg
Binu V. John
Publication date: 17-05-2022
Publisher: Springer US
Keyword: Fatty Liver
Published in: Digestive Diseases and Sciences / Issue 10/2022
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI: https://doi.org/10.1007/s10620-022-07512-w

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

MAFLD Versus NAFLD: Which Better Predicts the Risk of Atherosclerotic Cardiovascular Disease?

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 10/2022

Comparison of 2 L Polyethylene Glycol Plus Ascorbic Acid and 4 L Polyethylene Glycol in Elderly Patients Aged 60–79: A Prospective Randomized Study

Metformin Use Is Inversely Associated with Prevalent, but Not Incident Colorectal Adenomas

Geographic Distribution and Time Trends of Colorectal Cancer in Brazil from 2005 to 2018

Gastrocolic Reflex Is Delayed and Diminished in Adults with Type 1 Diabetes

Adjunctive Hyperbaric Oxygen Therapy for High Risk Peristomal Pyoderma Gangrenosum

Auricular Vagus Nerve Stimulation Ameliorates Functional Dyspepsia with Depressive-Like Behavior and Inhibits the Hypothalamus–Pituitary–Adrenal Axis in a Rat Model

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page